As of 2024-12-15, the Intrinsic Value of Design Therapeutics Inc (DSGN) is
-4.22 USD. This DSGN valuation is based on the model Peter Lynch Fair Value.
With the current market price of 5.60 USD, the upside of Design Therapeutics Inc is
-175.34%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
-4.22 USD
Intrinsic Value
DSGN Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
a |
Fair Value |
-4.22 - -4.22 |
-4.22 |
-175.34% |
P/E |
(15.86) - (16.17) |
(15.32) |
-373.5% |
DDM - Stable |
(7.10) - (24.02) |
(15.56) |
-377.9% |
DDM - Multi |
(9.32) - (24.78) |
(13.58) |
-342.4% |
DSGN Intrinsic Value - Key Valuation Metrics
Market Cap (mil) |
317.07 |
Beta |
2.30 |
Outstanding shares (mil) |
56.62 |
Enterprise Value (mil) |
286.74 |
Market risk premium |
4.60% |
Cost of Equity |
9.74% |
Cost of Debt |
5.00% |
WACC |
6.81% |